Humana Inc. (NYSE:HUM) Shares Sold by CIBC Asset Management Inc

CIBC Asset Management Inc lowered its stake in shares of Humana Inc. (NYSE:HUM) by 11.3% in the second quarter, HoldingsChannel reports. The fund owned 16,481 shares of the insurance provider’s stock after selling 2,101 shares during the quarter. CIBC Asset Management Inc’s holdings in Humana were worth $6,158,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Private Wealth Management Group LLC acquired a new position in shares of Humana during the 4th quarter valued at about $32,000. CarsonAllaria Wealth Management Ltd. increased its stake in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Hantz Financial Services Inc. acquired a new position in shares of Humana during the 2nd quarter valued at about $35,000. Family Firm Inc. acquired a new position in shares of Humana during the 2nd quarter valued at about $37,000. Finally, Carolinas Wealth Consulting LLC increased its stake in shares of Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after acquiring an additional 74 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Baird R W raised shares of Humana to a “hold” rating in a research note on Thursday, May 30th. Bank of America increased their target price on shares of Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research report on Monday, May 20th. Morgan Stanley started coverage on shares of Humana in a research report on Monday, June 24th. They set an “equal weight” rating and a $374.00 target price for the company. TD Cowen increased their target price on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Finally, Oppenheimer increased their target price on shares of Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $396.35.

Humana Stock Performance

Humana stock opened at $371.40 on Thursday. The stock has a market cap of $44.75 billion, a P/E ratio of 23.13, a price-to-earnings-growth ratio of 3.16 and a beta of 0.51. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock has a 50 day moving average of $367.95 and a 200-day moving average of $347.21. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $8.94 EPS. On average, analysts expect that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.95%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.